Node and Atrial Fibrillation Ablation for Persistent Atrial Fibrillation (NAFAPAF)

This is an interventional treatment trial for Persistent Atrial Fibrillation focused on measuring Atrial Fibrillation, Ablation Read More

Inclusion Criteria:

• Patients with symptomatic drug refractory atrial fibrillation.
• Patients who have had pacemaker implantation and AV node ablation with ongoing symptoms.
• Patients will already be refractory to at least 2 rate or rhythm control drugs.
• Patients must be over 18 years old.
• Patients give informed consent form prior to participating in this study.

Exclusion Criteria:

• Patient is suffering with unstable angina in last 1 week.
• Patient has had a myocardial infarction within last 2 months.
• Patient is expecting or has had major cardiac surgery within last 2 months.
• Patient is participating in a conflicting study.
• Patient is unable to perform exercise testing.
• Patient is mentally incapacitated and cannot consent or comply with follow-up.
• Patient has NYHA class III/ IV heart failure.
• Patient has LVEF <35% not secondary to tachycardia.
• Pregnancy.
• Patient suffers with other cardiac rhythm disorders.
• Recent coronary artery intervention or other factors suggesting clinical instability (ECG, clinical or laboratory findings).